ADMA Biologics Inc (ADMA)
17.40
-0.50
(-2.79%)
USD |
NASDAQ |
Dec 20, 16:00
17.47
+0.07
(+0.40%)
After-Hours: 20:00
ADMA Biologics Total Liabilities (Quarterly): 158.73M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 145.42M |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Catalyst Pharmaceuticals Inc | 111.07M |
| Sarepta Therapeutics Inc | 2.379B |
| Krystal Biotech Inc | 96.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 390.62M |
| Shareholders Equity (Quarterly) | 231.89M |
| Debt to Equity Ratio | 0.437 |
| Current Ratio | 7.088 |
| Net Debt Paydown Yield | 0.16% |